Paul A. Mahon is CLO & VP at UNITED THERAPEUTICS CORP (UTHR). They have made 51 open-market trades across 1 company since 2006, most recently 2026-10-15.
CIK 0001231589
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 51 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| UTHR | 45,172 | $24.1M |
Shares reported on the most recent Form 4, priced at the 2026-10-16 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| UTHR | SELL · 10b5-1 | 2026-10-15 | 2026-10-16 | $544.30 | $4.5M | — | — | — |
| UTHR | SELL · 10b5-1 | 2026-10-01 | 2026-10-01 | $564.95 | $4.7M | -4.6% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-17 | 2026-09-18 | $497.54 | $4.1M | +9.0% | — | — |
| UTHR | SELL · 10b5-1 | 2026-09-03 | 2026-09-03 | $482.03 | $4.0M | +2.3% | +10.2% | — |
| UTHR | SELL · 10b5-1 | 2026-08-20 | 2026-08-21 | $523.14 | $4.3M | -3.8% | -3.6% | — |
| UTHR | SELL · 10b5-1 | 2026-08-06 | 2026-08-06 | $517.05 | $4.3M | -2.6% | -6.4% | — |
| UTHR | SELL · 10b5-1 | 2026-07-16 | 2026-07-16 | $533.69 | $4.4M | -1.0% | -3.8% | +2.2% |
| UTHR | SELL · 10b5-1 | 2026-07-02 | 2026-07-02 | $552.56 | $4.6M | -3.8% | -6.6% | -1.9% |
| UTHR | SELL · 10b5-1 | 2026-06-18 | 2026-06-18 | $541.55 | $4.5M | +1.8% | -1.5% | -7.3% |
| UTHR | SELL · 10b5-1 | 2026-06-04 | 2026-06-04 | $547.07 | $4.5M | +0.7% | +0.5% | -9.6% |
| UTHR | SELL · 10b5-1 | 2026-05-21 | 2026-05-21 | $562.82 | $4.7M | -2.4% | -4.4% | -6.0% |
| UTHR | SELL · 10b5-1 | 2026-05-07 | 2026-05-07 | $586.75 | $4.9M | -0.5% | -4.4% | -9.0% |
| UTHR | SELL · 10b5-1 | 2026-04-16 | 2026-04-16 | $576.82 | $4.8M | -1.6% | -2.0% | -8.1% |
| UTHR | SELL · 10b5-1 | 2026-04-02 | 2026-04-02 | $565.87 | $4.7M | +2.0% | +2.7% | -3.4% |
| UTHR | SELL · 10b5-1 | 2026-03-19 | 2026-03-19 | $530.10 | $8.0M | +13.5% | +9.7% | +5.5% |
| UTHR | SELL | 2026-03-05 | 2026-03-05 | $483.16 | $4.0M | +13.0% | +17.1% | +14.9% |
| UTHR | SELL | 2026-02-19 | 2026-02-19 | $476.34 | $4.0M | +4.1% | +8.8% | +17.8% |
| UTHR | SELL | 2026-02-05 | 2026-02-05 | $483.25 | $4.0M | -1.6% | +9.4% | +23.3% |
| UTHR | SELL | 2026-01-15 | 2026-01-15 | $469.89 | $3.9M | -0.3% | +2.9% | +23.2% |
| UTHR | SELL | 2026-01-02 | 2026-01-02 | $485.43 | $4.0M | -4.3% | -4.4% | +13.7% |
| UTHR | SELL · 10b5-1 | 2025-12-24 | 2025-12-29 | $513.17 | $11.2M | -3.9% | -7.1% | +17.0% |
| UTHR | SELL · 10b5-1 | 2025-12-11 | 2025-12-12 | $484.68 | $10.0M | +4.7% | -1.9% | +8.3% |
| UTHR | SELL · 10b5-1 | 2025-11-26 | 2025-11-26 | $486.07 | $10.7M | -2.8% | +3.4% | -3.4% |
| UTHR | SELL · 10b5-1 | 2025-11-13 | 2025-11-13 | $464.83 | $10.1M | +5.5% | +8.7% | +3.4% |
| UTHR | SELL · 10b5-1 | 2025-10-30 | 2025-10-30 | $450.34 | $9.9M | +1.7% | +6.3% | +3.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.